TV2-12696-28962
4 vaccinations
2 coded responses
28 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 871 / NM
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
-
2021-01-11
Survey response — day 14, dose 1MedDRA: Constipation, Injection site erythema, Nausea — Feeling: GoodFree text: One week after injection I had nausea and constipation for 2 days and redness at the injection site one day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-23
- 2021-01-24
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-27
Health check-in — day 7, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-11-19
Dose 3 — Moderna
- 2022-01-20
- 2022-05-20
-
2022-11-19
Survey response — 12 months, dose 3MedDRA: COVID-19, Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Covid, pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-11-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-11
Dose 4 — Moderna
- 2023-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Moderna | No |
| 4 | 2023-02-11 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 1 — day 14, dose 1
Symptoms: One week after injection I had nausea and constipation for 2 days and redness at the injection site one day.
Release 12 — 12 months, dose 3
Symptoms: Covid, pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Constipation | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release